South Metropolitan Health Service
1 clinical trials · Sponsor
◉ Watch South Metropolitan Health Service
| Record | Firm | Date |
|---|---|---|
| Phase I Study to Evaluate the Diagnostic Performance of 89Zirconium Girentuximab PET in Urothelial Cancer Patients (NCT05046665) | South Metropolitan Health Service | 2021-05-14 |
Track South Metropolitan Health Service automatically
Every clearance here is in the API, with alerts when new ones post.